Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Cofetuzumab pelidotin |
| Trade Name | |
| Synonyms | h6M24-vc0101|PTK7-targeted antibody-drug conjugate|ABBV-647|PF-06647020 |
| Drug Descriptions |
Cofetuzumab pelidotin (PF-06647020) is an antibody-drug conjugate comprising a monoclonal antibody against PTK7 linked to Aur0101, which delivers the cytotoxic agent to PTK7-expressing tumor cells, leading to cell death (PMID: 28077676). |
| DrugClasses | |
| CAS Registry Number | 1869937-48-3 |
| NCIT ID | C123828 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Avelumab + Cofetuzumab pelidotin | Avelumab Cofetuzumab pelidotin | 0 | 1 |
| Cofetuzumab pelidotin | Cofetuzumab pelidotin | 0 | 2 |
| Cofetuzumab pelidotin + Gedatolisib | Cofetuzumab pelidotin Gedatolisib | 0 | 1 |